124 related articles for article (PubMed ID: 33471656)
21. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
Penttilä TL; Koskinen P; Penttilä TA; Anttila L; Irjala K
Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782
[TBL] [Abstract][Full Text] [Related]
22. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
23. The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
Łebkowska A; Adamska A; Krentowska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Hryniewicka J; Leśniewska M; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
J Clin Endocrinol Metab; 2021 May; 106(6):1811-1820. PubMed ID: 33537700
[TBL] [Abstract][Full Text] [Related]
24. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
[TBL] [Abstract][Full Text] [Related]
25. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
[TBL] [Abstract][Full Text] [Related]
26. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
27. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
28. Changes in androgens during treatment with four low-dose contraceptives.
Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
[TBL] [Abstract][Full Text] [Related]
29. Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.
Cho LW; Sathyapalan T; Kilpatrick ES; Keevil BG; Miller AG; Coady AM; Ahmed L; Atkin SL
BMC Endocr Disord; 2017 May; 17(1):26. PubMed ID: 28525998
[TBL] [Abstract][Full Text] [Related]
30. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC
J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874
[TBL] [Abstract][Full Text] [Related]
31. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
[TBL] [Abstract][Full Text] [Related]
32. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
[TBL] [Abstract][Full Text] [Related]
33. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
Kumarendran B; O'Reilly MW; Manolopoulos KN; Toulis KA; Gokhale KM; Sitch AJ; Wijeyaratne CN; Coomarasamy A; Arlt W; Nirantharakumar K
PLoS Med; 2018 Mar; 15(3):e1002542. PubMed ID: 29590099
[TBL] [Abstract][Full Text] [Related]
34. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.
Taponen S; Martikainen H; Järvelin MR; Laitinen J; Pouta A; Hartikainen AL; Sovio U; McCarthy MI; Franks S; Ruokonen A
J Clin Endocrinol Metab; 2003 Jan; 88(1):141-7. PubMed ID: 12519843
[TBL] [Abstract][Full Text] [Related]
35. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
Yildiz BO; Woods KS; Stanczyk F; Bartolucci A; Azziz R
J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
[TBL] [Abstract][Full Text] [Related]
36. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
[TBL] [Abstract][Full Text] [Related]
37. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
Montalto J; Whorwood CB; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
[TBL] [Abstract][Full Text] [Related]
38. Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
Dambala K; Vavilis D; Bili E; Goulis DG; Tarlatzis BC
Gynecol Endocrinol; 2017 Jul; 33(7):529-533. PubMed ID: 28300464
[TBL] [Abstract][Full Text] [Related]
39. Comparison Of Free Androgen Index In Polycystic Ovary Syndrome And Non-Polycystic Ovary Syndrome Infertile Patients.
Khattak M; Usman R; Sultana N; Khattak A
J Ayub Med Coll Abbottabad; 2021; 33(4):577-581. PubMed ID: 35124911
[TBL] [Abstract][Full Text] [Related]
40. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
